Intel’s Comeback: From Chip Loser to Musk’s Manufacturing Partner

For years, Intel has been the punching bag of the semiconductor industry. While Nvidia soared on AI demand and AMD ate into its server market share, Intel struggled with manufacturing delays, declining margins, and a stock price that halved from its 2021 highs.

Then, on April 7, 2026, CEO Lip-Bu Tan announced something that no one expected: a partnership with Elon Musk's "Terafab" project — an ambitious plan to produce one terawatt of annual compute capacity to power Tesla's humanoid robots and SpaceX's space-based data centers. Intel shares jumped 3% on the news.

This is not just another press release. It represents a potential inflection point for a company that has been written off by most of Wall Street. The question for investors is whether this is a genuine turning point — or just another chapter in Intel's long saga of overpromising and underdelivering.

See how institutional investors are positioning in our Smart Money Tracker. Our full analysis, including a detailed financial model, competitive positioning assessment, and price target, is available to BMInsider PRO members below.

[membership level="2,5,6,7"]

Understanding the Terafab Partnership

The Terafab project is Elon Musk's most ambitious manufacturing vision since the Tesla Gigafactory. The concept is simple but staggering in scale: build facilities in Austin, Texas capable of producing one terawatt of compute annually — enough to power millions of AI-driven humanoid robots and support SpaceX's plans for orbital data centers.

Intel's role in this ecosystem is as a foundry partner — manufacturing the advanced logic chips that will drive these systems. This is precisely the market that Intel has been positioning for since Pat Gelsinger launched the IDM 2.0 strategy in 2021, and which Lip-Bu Tan has aggressively pursued since taking over as CEO.

The strategic significance cannot be overstated. Intel has struggled to win foundry customers against TSMC's dominance. Landing Musk — whose companies collectively represent one of the largest potential consumers of advanced silicon in the world — provides both a revenue anchor and a credibility signal that could attract additional customers.

Financial Analysis

Intel's financials remain challenged but are showing early signs of stabilization. Revenue for Q4 2025 came in at $14.3 billion, roughly flat year-over-year but above the $13.8 billion consensus. Gross margins have stabilized at approximately 42%, up from the trough of 38% in mid-2024.

The company's foundry segment remains unprofitable, with estimated operating losses of $5–7 billion annually. However, this is expected — building a world-class foundry business requires massive upfront investment before scale economics kick in. TSMC's own foundry business was unprofitable for its first decade.

The critical metric for Intel investors is the 18A process node. The company has stated that 18A is on track for volume production in late 2026, and multiple customers have signed up for test wafers. If 18A delivers on its performance promises — competitive with TSMC's N2 node — it would represent the most significant manufacturing achievement in Intel's recent history.

The Terafab partnership potentially accelerates 18A's commercial viability by providing a large, committed customer willing to place advance orders. This is exactly the kind of demand signal that could tip other potential foundry customers — including US defense contractors and automotive chipmakers — toward Intel.

Valuation

At the current price of approximately $25, Intel trades at roughly 20x forward earnings — expensive by its historical standards but potentially cheap if the foundry turnaround materializes.

Our base case assumes: moderate foundry revenue ramp beginning in 2027, stabilization of the PC and data center businesses, and continued government support through the CHIPS Act. This yields a fair value of $30–35, representing 20–40% upside.

Our bull case, which assigns a higher probability to Terafab-driven foundry success, yields a fair value of $45–50 — roughly double the current price. This scenario requires successful 18A production, multiple additional foundry wins, and a resolution of the Iran crisis that alleviates the broader market headwinds.

Our bear case, which assumes continued foundry losses without meaningful customer wins, yields a fair value of $15–18 — roughly 30–40% downside.

Risk Factors

The risks to Intel's turnaround are substantial. The 18A process node could encounter manufacturing challenges that delay volume production. TSMC could respond aggressively on pricing. The Terafab partnership could prove less meaningful than the headline suggests — Musk's companies are known for announcing ambitious plans that evolve significantly during execution.

Additionally, Intel's balance sheet is becoming a concern. The company recently announced plans to repurchase a 49% stake in its Irish Fab 34 plant from Apollo Global Management for $14.2 billion — a significant capital commitment at a time when free cash flow is negative.

Conclusion

Intel at $25 is a high-risk, high-reward position. The Terafab partnership is a genuine positive catalyst, but it does not eliminate the execution risks that have plagued the company for years. For investors with a 2–3 year horizon and tolerance for volatility, a moderate position with the understanding that the outcome is binary — either the foundry strategy works and the stock doubles, or it doesn't and the stock halves — is a reasonable approach.

We rate Intel as a speculative buy with a base-case target of $32 and a 24-month time horizon.

[/membership]

[membership level="-2,-5,-6,-7"]

[/membership]